Journal of Ginseng Research

The Korean Society of Ginseng (고려인삼학회)
권호 표지
DOI QR코드

DOI QR Code

Anti-Cancer Effect of Ginsenoside F2 against Glioblastoma Multiforme in Xenograft Model in SD Rats

  • Shin, Ji-Yon (Graduate School of Biotechnology, Kyung Hee University) ;
  • Lee, Jung-Min (Graduate School of Biotechnology, Kyung Hee University) ;
  • Shin, Heon-Sub (Graduate School of Biotechnology, Kyung Hee University) ;
  • Park, Sang-Yong (Graduate School of Biotechnology, Kyung Hee University) ;
  • Yang, Jung-Eun (Graduate School of Biotechnology, Kyung Hee University) ;
  • KimCho, So-Mi (Faculty of Biotechnology, Jeju National University) ;
  • Yi, Tae-Hoo (Graduate School of Biotechnology, Kyung Hee University)
  • Received : 2011.08.16
  • Accepted : 2011.10.27
  • Published : 2012.01.11
Download PDF
⟨ Previous Next ⟩

Abstract

The glioblastoma multiforme (GBM) is the most common malignant brain tumor in adults. Despite combination treatments of radiation and chemotherapy, the survival periods are very short. Therefore, this study was conducted to assess the potential of ginsenoside $F_2$ (F2) to treat GBM. In in vitro experiments with glioblastoma cells U373MG, F2 showed the cytotoxic effect with $IC_{50}$ of 50 ${\mu}g/mL$ through apoptosis, confirmed by DNA condensation and fragmentation. The cell population of cell cycle sub-G1 as indicative of apoptosis was also increased. In xenograft model in SD rats, F2 at dosage of 35 mg/kg weight was intravenously injected every two days. This reduced the tumor growth in magnetic resonance imaging images. The immunohistochemistry revealed that the anticancer activity might be mediated through inhibition of proliferation judged by Ki67 and apoptosis induced by activation of caspase-3 and -8. And the lowered expression of CD31 showed the reduction in blood vessel densities. The expression of matrix metalloproteinase-9 for invasion of cancer was also inhibited. The cell populations with cancer stem cell markers of CD133 and nestin were reduced. The results of this study suggested that F2 could be a new potential chemotherapeutic drug for GBM treatment by inhibiting the growth and invasion of cancer.

Keywords

References

  1. Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med 2008;359:492-507. https://doi.org/10.1056/NEJMra0708126
  2. Claes A, Idema AJ, Wesseling P. Diffuse glioma growth: a guerilla war. Acta Neuropathol 2007;114:443-458. https://doi.org/10.1007/s00401-007-0293-7
  3. Lefranc F, Brotchi J, Kiss R. Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J Clin Oncol 2005;23:2411-2422. https://doi.org/10.1200/JCO.2005.03.089
  4. Cheng L, Bao S, Rich JN. Potential therapeutic implications of cancer stem cells in glioblastoma. Biochem Pharmacol 2010;80:654-665. https://doi.org/10.1016/j.bcp.2010.04.035
  5. Hasegawa H, Sung JH, Matsumiya S, Uchiyama M. Main ginseng saponin metabolites formed by intestinal bacteria. Planta Med 1996;62:453-457. https://doi.org/10.1055/s-2006-957938
  6. Choi S, Oh JY, Kim SJ. Ginsenoside $Rh_2$ induces Bcl-2 family proteins-mediated apoptosis in vitro and in xenografts in vivo models. J Cell Biochem 2011;112:330-340. https://doi.org/10.1002/jcb.22932
  7. Kim SY, Kim DH, Han SJ, Hyun JW, Kim HS. Repression of matrix metalloproteinase gene expression by ginsenoside Rh2 in human astroglioma cells. Biochem Pharmacol 2007;74:1642-1651. https://doi.org/10.1016/j.bcp.2007.08.015
  8. Jung SH, Woo MS, Kim SY, Kim WK, Hyun JW, Kim EJ, Kim DH, Kim HS. Ginseng saponin metabolite suppresses phorbol ester-induced matrix metalloproteinase-9 expression through inhibition of activator protein-1 and mitogen-activated protein kinase signaling pathways in human astroglioma cells. Int J Cancer 2006;118:490-497. https://doi.org/10.1002/ijc.21356
  9. Kruse AJ, Baak JP, Janssen EA, Kjellevold KH, Fiane B, Lovslett K, Bergh J, Robboy S. Ki67 predicts progression in early CIN: validation of a multivariate progression-risk model. Cell Oncol 2004;26:13-20.
  10. Ye R, Kong X, Yang Q, Zhang Y, Han J, Li P, Xiong L, Zhao G. Ginsenoside rd in experimental stroke: superior neuroprotective effi cacy with a wide therapeutic window. Neurotherapeutics 2011;8:515-525. https://doi.org/10.1007/s13311-011-0051-3
  11. Kim YS, Jin SH. Ginsenoside $Rh_2$ induces apoptosis via activation of caspase-1 and -3 and up-regulation of Bax in human neuroblastoma. Arch Pharm Res 2004;27:834-839. https://doi.org/10.1007/BF02980175
  12. Rao JS, Steck PA, Mohanam S, Stetler-Stevenson WG, Liotta LA, Sawaya R. Elevated levels of M(r) 92,000 type IV collagenase in human brain tumors. Cancer Res 1993;53(10 Suppl):2208-2211.
  13. Sawaya R, Go Y, Kyritisis AP, Uhm J, Venkaiah B, Mohanam S, Gokaslan ZL, Rao JS. Elevated levels of Mr 92,000 type IV collagenase during tumor growth in vivo. Biochem Biophys Res Commun 1998;251:632-636. https://doi.org/10.1006/bbrc.1998.9466
  14. Joo KM, Kim SY, Jin X, Song SY, Kong DS, Lee JI, Jeon JW, Kim MH, Kang BG, Jung Y et al. Clinical and biological implications of CD133-positive and CD133- negative cells in glioblastomas. Lab Invest 2008;88:808-815. https://doi.org/10.1038/labinvest.2008.57
  15. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB. Identifi cation of human brain tumour initiating cells. Nature 2004;432:396-401. https://doi.org/10.1038/nature03128
  16. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich JN. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006;444:756-760. https://doi.org/10.1038/nature05236
  17. Bruno S, Bussolati B, Grange C, Collino F, Graziano ME, Ferrando U, Camussi G. CD133+ renal progenitor cells contribute to tumor angiogenesis. Am J Pathol 2006;169:2223-2235. https://doi.org/10.2353/ajpath.2006.060498

Cited by

  1. Biotransformation, a Promising Technology for Anti-cancer Drug Development vol.14, pp.10, 2013, https://doi.org/10.7314/APJCP.2013.14.10.5599
  2. Highly selective hydrolysis for the outer glucose at the C-20 position in ginsenosides by β-glucosidase from Thermus thermophilus and its application to the production of ginsenoside F2 from gypenoside XVII vol.36, pp.6, 2014, https://doi.org/10.1007/s10529-014-1472-y
  3. Characterization of a Ginsenoside-Transforming β-glucosidase from Paenibacillus mucilaginosus and Its Application for Enhanced Production of Minor Ginsenoside F2 vol.9, pp.1, 2014, https://doi.org/10.1371/journal.pone.0085727
  4. Ginseng Purified Dry Extract, BST204, Improved Cancer Chemotherapy-Related Fatigue and Toxicity in Mice vol.2015, pp.1741-4288, 2015, https://doi.org/10.1155/2015/197459
  5. Inhibition of autophagosome-lysosome fusion by ginsenoside Ro via the ESR2-NCF1-ROS pathway sensitizes esophageal cancer cells to 5-fluorouracil-induced cell death via the CHEK1-mediated DNA damage checkpoint vol.12, pp.9, 2016, https://doi.org/10.1080/15548627.2016.1192751
  6. on Human Gastric Carcinoma Cells SGC7901 vol.2016, pp.1741-4288, 2016, https://doi.org/10.1155/2016/2635483
  7. Anticancer Activities of Protopanaxadiol- and Protopanaxatriol-Type Ginsenosides and Their Metabolites vol.2016, pp.1741-4288, 2016, https://doi.org/10.1155/2016/5738694
  8. Targeting cancer stem-like cells using dietary-derived agents - Where are we now? vol.60, pp.6, 2016, https://doi.org/10.1002/mnfr.201500887
  9. vol.64, pp.12, 2016, https://doi.org/10.1021/acs.jafc.5b04098
  10. -induced apoptosis in HEK-293 cells via the NF-κB pathway vol.7, pp.66, 2017, https://doi.org/10.1039/C7RA04689H
  11. A New Application of Charged Aerosol Detection in Liquid Chromatography for the Simultaneous Determination of Polar and Less Polar Ginsenosides in Ginseng Products vol.24, pp.4, 2013, https://doi.org/10.1002/pca.2419
  12. -Mix on Lipopolysaccharide-Stimulated RAW 264.7 Murine Macrophage Cells vol.21, pp.10, 2018, https://doi.org/10.1089/jmf.2018.4180
  13. Ginsenoside Rp1 Exerts Anti-inflammatory Effects via Activation of Dendritic Cells and Regulatory T Cells vol.36, pp.4, 2012, https://doi.org/10.5142/jgr.2012.36.4.375
  14. Enzymatic Biotransformation of Ginsenoside Rb1 and Gypenoside XVII into Ginsenosides Rd and F2 by Recombinant β-glucosidase from Flavobacterium johnsoniae vol.36, pp.4, 2012, https://doi.org/10.5142/jgr.2012.36.4.418
  15. Quercetin Induces Mitochondrial Mediated Apoptosis and Protective Autophagy in Human Glioblastoma U373MG Cells vol.2013, pp.None, 2012, https://doi.org/10.1155/2013/596496
  16. A ginseng metabolite, compound K, induces autophagy and apoptosis via generation of reactive oxygen species and activation of JNK in human colon cancer cells vol.4, pp.None, 2012, https://doi.org/10.1038/cddis.2013.273
  17. Quality and characteristics of ginseng seed oil treated using different extraction methods vol.37, pp.4, 2013, https://doi.org/10.5142/jgr.2013.37.468
  18. Individual and combined antioxidant effects of ginsenoside F2 and cyanidin-3-O-glucoside in human embryonic kidney 293 cells vol.6, pp.84, 2012, https://doi.org/10.1039/c6ra14831j
  19. Biosynthesis of Plant Triterpenoid Saponins in Microbial Cell Factories vol.66, pp.46, 2018, https://doi.org/10.1021/acs.jafc.8b04657
  20. Change of Ginsenoside Profiles in Processed Ginseng by Drying, Steaming, and Puffing vol.29, pp.2, 2012, https://doi.org/10.4014/jmb.1809.09056
  21. Neuroprotective Effects of Ginsenosides against Cerebral Ischemia vol.24, pp.6, 2019, https://doi.org/10.3390/molecules24061102
  22. Anti-Metastatic and Anti-Inflammatory Effects of Matrix Metalloproteinase Inhibition by Ginsenosides vol.9, pp.2, 2021, https://doi.org/10.3390/biomedicines9020198
  23. Comparison of ginsenoside (Rg1, Rb1) content and radical-scavenging activities of wild-simulated ginseng extract with respect to the solvent vol.28, pp.2, 2012, https://doi.org/10.11002/kjfp.2021.28.2.261
  24. Phnomibacter ginsenosidimutans gen. nov., sp. nov., a novel glycoside hydrolase positive bacterial strain with ginsenoside hydrolysing activity vol.71, pp.5, 2021, https://doi.org/10.1099/ijsem.0.004793